CDNF and MANF in the brain dopamine system and their potential as treatment for Parkinson’s disease

Parkinson’s disease (PD) is a progressive neurodegenerative disease characterized by gradual loss of midbrain dopamine neurons, leading to impaired motor function. Preclinical studies have indicated cerebral dopamine neurotrophic factor (CDNF) and mesencephalic astrocyte-derived neurotrophic factor...

Descripción completa

Detalles Bibliográficos
Autores principales: Pakarinen, Emmi, Lindholm, Päivi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10405524/
https://www.ncbi.nlm.nih.gov/pubmed/37555005
http://dx.doi.org/10.3389/fpsyt.2023.1188697

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10405524/
https://www.ncbi.nlm.nih.gov/pubmed/37555005
http://dx.doi.org/10.3389/fpsyt.2023.1188697

Ejemplares similares